Raul Rabadan Selected Research

RNA Splice Sites

1/2021	Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis.
12/2020	Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulation.
1/2020	Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raul Rabadan Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 04/2010
13	Glioblastoma (Glioblastoma Multiforme) 03/2022 - 09/2014
12	Glioma (Gliomas) 10/2021 - 09/2012
6	Lymphoma (Lymphomas) 01/2021 - 08/2012
6	Leukemia 01/2021 - 04/2010
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 02/2014
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 06/2020 - 07/2013
5	Human Influenza (Influenza) 11/2015 - 08/2009
4	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 10/2018
4	Melanoma (Melanoma, Malignant) 01/2020 - 06/2014
4	Infections 01/2017 - 11/2010
3	Genomic Instability 01/2021 - 01/2016
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2020 - 02/2012
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 03/2011
2	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 10/2016
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2019
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2019 - 02/2014
2	Disease Progression 01/2019 - 03/2013
2	Virus Diseases (Viral Diseases) 01/2018 - 12/2015
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2017 - 02/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017 - 03/2011
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2016 - 04/2010
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2014 - 12/2011
1	Anemia 01/2022
1	Dehydration (Water Stress) 10/2021
1	Neurofibrosarcoma (MPNST) 10/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 03/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021
1	Chromosome Breakage 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	Carcinogenesis 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2020
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Hyperglycemia 12/2019
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Ischemia 01/2018

Drug/Important Bio-Agent (IBA)

9	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2013
9	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 05/2010
8	Phosphotransferases (Kinase)IBA 01/2022 - 09/2012
8	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2009
7	Pharmaceutical PreparationsIBA 01/2022 - 04/2017
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
3	RNA Splice SitesIBA 01/2021 - 01/2020
3	RNA Splicing FactorsIBA 12/2020 - 12/2011
3	VaccinesIBA 01/2013 - 09/2010
2	ChromatinIBA 10/2021 - 01/2021
2	EnzymesIBA 10/2021 - 01/2018
2	Alkylating AgentsIBA 01/2020 - 12/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2019
2	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 01/2018
2	Immune Checkpoint InhibitorsIBA 12/2019 - 01/2019
2	Biological ProductsIBA 01/2017 - 01/2016
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 01/2016
2	Protein Tyrosine PhosphatasesIBA 10/2016 - 01/2016
2	Anaplastic Lymphoma KinaseIBA 01/2016 - 07/2013
2	fludarabineIBA 04/2014 - 12/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 10/2021
1	pexidartinibIBA 10/2021
1	Sirolimus (Rapamycin)FDA Link 10/2021
1	TransposasesIBA 10/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2021
1	NivolumabIBA 03/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	LigandsIBA 01/2021
1	PyrimidinesIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 11/2020
1	Janus Kinase InhibitorsIBA 06/2020
1	ruxolitinibIBA 06/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2020
1	MidkineIBA 12/2019
1	Conditioned Culture MediaIBA 12/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2019
1	Glucagon (Glukagon)FDA Link 12/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2019
1	Dasatinib (BMS 354825)FDA Link 01/2019
1	Decitabine FDA Link 01/2019
1	APTIBA 01/2019
1	ibrutinibIBA 10/2018
1	CreatinineIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018

Therapy/Procedure

21	Therapeutics 01/2022 - 08/2012
7	Immunotherapy 03/2022 - 01/2018
4	Drug Therapy (Chemotherapy) 11/2020 - 03/2013
3	Precision Medicine 06/2020 - 04/2017
2	Combination Drug Therapy (Combination Chemotherapy) 11/2020 - 10/2016
1	Traction 01/2022
1	Castration 11/2020
1	Breast Implants (Breast Implant) 06/2020
1	Transplantation 01/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2019
1	Radiotherapy 01/2018